Literature DB >> 26724322

Specific Antinuclear Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis Are Associated with Improvement of Skin Thickening.

Carolien Bonroy1, Vanessa Smith2, Ellen Deschepper3, Filip De Keyser2, Katrien Devreese4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26724322     DOI： 10.3899/jrheum.150105

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

Review 1.  Systemic sclerosis with anti-RNA polymerase III positivity following silicone breast implant rupture: possible role of B-cell depletion and implant removal in the treatment.

Authors:  Francesca Dall'Ara; Maria-Grazia Lazzaroni; Chiara M Antonioli; Paolo Airò
Journal:  Rheumatol Int       Date:  2017-02-03       Impact factor: 2.631

Review 2.  Anti-RNA polymerase III antibodies in patients with suspected and definite systemic sclerosis: Why and how to screen.

Authors:  Maria-Grazia Lazzaroni; Paolo Airò
Journal:  J Scleroderma Relat Disord       Date:  2018-07-13

Review 3.  Systemic sclerosis phase III clinical trials: Hope on the horizon?

Authors:  Martin Aringer; Christopher P Denton
Journal:  J Scleroderma Relat Disord       Date:  2018-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.